1. Anticancer drug pharmacodynamics

   • Garth Powis

   Review Pages: 177 - 183

2. The antitumor effects of human lymphoblastoid interferon on human renal cell carcinoma in athymic nude mice

   • Takashi Yamaoka
   • Hiroshi Takada
   • Yoshio Sakurai

   Original Articles Pages: 184 - 187

3. Prevention of cyclophosphamide-induced urotoxicity by reduced glutathione and its effect on acute toxicity and antitumor activity of the alkylating agent

   • Odoardo Tofanetti
   • Ennio Cavalletti
   • Franco Zunino

   Original Articles Pages: 188 - 193

4. Identification of anthracycline analogues with enhanced cytotoxicity and lack of cross-resistance to adriamycin using a series of mammalian cell lines in vitro

   • Bridget T. Hill
   • Lorraine Y. Dennis
   • Richard D. H. Whelan

   Original Articles Pages: 194 - 201

5. Inhibition of growth of leukemic cells by inhibitors of calmodulin: Phenothiazines and melittin

   • William N. Hait
   • Linda Grais
   • Ed. C. Cadman

   Original Articles Pages: 202 - 205

6. Biologic and pharmacologic effects of harringtonine on human leukemia-lymphoma cells

   • Yuzuru Takemura
   • Takao Ohnuma
   • James F. Holland

   Original Articles Pages: 206 - 210

7. Small intestinal transit time affects methotrexate absorption in children with acute lymphoblastic leukemia

   • A. D. J. Pearson
   • A. W. Craft
   • A. N. Campbell

   Original Articles Pages: 211 - 215

8. Phase-I–II study of high-dose melphalan and autologous marrow transplantation in adult patients with poor-risk non-Hodgkin's lymphomas

   • B. Mascret
   • D. Maraninchi
   • Y. Carcassonne

   Original Articles Pages: 216 - 221

9. Hexamethylmelamine, adriamycin, and cyclophosphamide (HAC) versus cis-dichlorodiamineplatinum, adriamycin, and cyclophosphamide (PAC) in advanced ovarian cancer: A randomized clinical trial

   • Cristiana Sessa
   • Giorgio Bolis
   • Costantino Mangioni

   Original Articles Pages: 222 - 228

10. Medroxyprogesterone acetate (MAP) and tamoxifen (TMX) plasma levels after simultaneous treatment with ‘low’ TMX and ‘high’ MAP doses

    • Carlo M. Camaggi
    • Elena Strocchi
    • Franco Pannuti

    Original Articles Pages: 229 - 231

11. Medroxyprogesterone acetate bioavailability after high-dose intraperitoneal administration in advanced cancer

    • Carlo M. Camaggi
    • Elena Strocchi
    • Franco Pannuti

    Original Articles Pages: 232 - 234

12. Methylprednisolone as an antiemetic drug

    • D. Schallier
    • S. Van Belle
    • A. Willekens

    Original Articles Pages: 235 - 237

13. The distribution and elimination of methotrexate in mouse blood and brain after concurrent administration of polysorbate 80

    • M. Noor Azmin
    • James F. B. Stuart
    • Alexander T. Florence

    Original Articles Pages: 238 - 242

14. Amelioration of doxorubicin-induced skin necrosis in mice by butylated hydroxytoluene

    • J. Patrick Daugherty
    • Atul Khurana

    Original Articles Pages: 243 - 246

15. Beta-2-microglobulin excretion: An indicator of long term nephrotoxicity during cis-platinum treatment?

    • Peter Grundtvig Sørensen
    • Mogens H. Nissen
    • Mikael Rørth

    Original Articles Pages: 247 - 249

16. High-dose intravenous metoclopramide and intermittent intramuscular prochlorperazine and diazepam in the management of emesis induced by cis-dichlorodiammineplatinum

    • D. M. Luesley
    • P. B. Terry
    • K. K. Chan

    Original Articles Pages: 250 - 252

17. In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum(II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (IV), cis-dichloro-bis-cyclopropylamine platinum(II), and cis-diammine 1,1-cyclobutanedicarboxylate platinum(II) in patients with malignant disease, using a gamma camera

    • S. E. Owens
    • N. Thatcher
    • B. W. Fox

    Original Articles Pages: 253 - 257

18. Cis-dichlorodiammineplatinum (Cis-platinum) and etoposide (VP-16) in malignant lymphoma — an effective salvage regimen

    • I. R. Judson
    • E. Wiltshaw

    Original Articles Pages: 258 - 261

19. The effect of captopril on renal function in patients during the first cis-diamminedichloroplatinum II infusion

    • Joop J. G. Offerman
    • Dirk Th. Sleijfer
    • Ab J. M. Donker

    Original Articles Pages: 262 - 264

20. The clinical pharmacokinetics of the novel antifolate N¹⁰-propargyl-5,8-dideazafolic acid (CB 3717)

    • Dawn L. Alison
    • David R. Newell
    • A. Hilary Calvert

    Original Articles Pages: 265 - 271

21. A randomised trial of tamoxifen versus tamoxifen with aminoglutethimide in post-menopausal women with advanced breast cancer

    • R. Milsted
    • T. Habeshaw
    • K. Calman

    Short Communication Pages: 272 - 273

22. A pharmacokinetic evaluation of IM administration of bleomycin oil suspension

    • Margaret Davy
    • Elisabeth Paus
    • Gustav Lehne

    Short Communication Pages: 274 - 276

23. Combination chemotherapy of advanced renal cell cancer with CCNU and vinblastine

    • Hilde Heen Sommer
    • Sophie Dorothea Fosså
    • Hans Henrik Lien

    Short Communication Pages: 277 - 278

24. Melphalan-resistant multiple myeloma: results of treatment according to the M-2 protocol

    • B. Steinke
    • F. W. Busch
    • H. D. Waller

    Short Communication Pages: 279 - 281

25. Cyclic combination chemotherapy in advanced adenocarcinoma of the lung: Comparison of two FAM schedules

    • W. K. Lam
    • S. Y. So
    • Donald Y. C. Yu

    Short Communication Pages: 282 - 283

26. Meeting announcements

    Announcement Pages: 284 - 284